Ironwood Pharmaceuticals Inc (IRWD)
6.475
-0.16
(-2.48%)
USD |
NASDAQ |
May 17, 16:00
6.475
0.00 (0.00%)
After-Hours: 20:00
Ironwood Pharmaceuticals Accounts Receivable (Quarterly): 72.02M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 72.02M |
December 31, 2023 | 129.12M |
September 30, 2023 | 124.55M |
June 30, 2023 | 118.99M |
March 31, 2023 | 115.75M |
December 31, 2022 | 115.46M |
September 30, 2022 | 116.54M |
June 30, 2022 | 102.36M |
March 31, 2022 | 105.52M |
December 31, 2021 | 114.04M |
September 30, 2021 | 101.77M |
June 30, 2021 | 102.25M |
March 31, 2021 | 87.15M |
December 31, 2020 | 122.35M |
September 30, 2020 | 113.25M |
June 30, 2020 | 105.38M |
March 31, 2020 | 91.11M |
December 31, 2019 | 117.25M |
September 30, 2019 | 96.57M |
June 30, 2019 | 103.79M |
March 31, 2019 | 72.62M |
December 31, 2018 | 80.95M |
September 30, 2018 | 65.38M |
June 30, 2018 | 80.52M |
March 31, 2018 | 70.65M |
Date | Value |
---|---|
December 31, 2017 | 82.16M |
September 30, 2017 | 80.08M |
June 30, 2017 | 60.36M |
March 31, 2017 | 51.15M |
December 31, 2016 | 64.85M |
September 30, 2016 | 53.72M |
June 30, 2016 | 53.15M |
March 31, 2016 | 53.02M |
December 31, 2015 | 54.52M |
September 30, 2015 | 36.97M |
June 30, 2015 | 27.05M |
March 31, 2015 | 33.85M |
December 31, 2014 | 25.84M |
September 30, 2014 | 14.69M |
June 30, 2014 | 4.455M |
March 31, 2014 | 10.34M |
December 31, 2013 | 3.213M |
September 30, 2013 | 3.086M |
June 30, 2013 | 5.298M |
March 31, 2013 | 0.048M |
December 31, 2012 | 1.487M |
September 30, 2012 | 0.182M |
June 30, 2012 | 2.466M |
March 31, 2012 | 0.109M |
December 31, 2011 | 0.652M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
72.02M
Minimum
Mar 2024
129.12M
Maximum
Dec 2023
107.76M
Average
109.38M
Median
Accounts Receivable (Quarterly) Benchmarks
AbbVie Inc | 11.95B |
Societal CDMO Inc (DELISTED) | 16.58M |
Amicus Therapeutics Inc | 76.43M |
Insmed Inc | 37.16M |
InfuSystems Holdings Inc | 20.54M |